Your browser doesn't support javascript.
loading
A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.
Hills, N K; Lyimo, J; Nahid, P; Savic, R M; Lienhardt, C; Phillips, P P J.
Affiliation
  • Hills NK; UCSF Department of Epidemiology & Biostatistics, San Francisco, California, USA.
  • Lyimo J; MDR-TB Coordinator-National TB and Leprosy Program, Ministry of Health, Dodoma, Tanzania.
  • Nahid P; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA.
  • Savic RM; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA.
  • Lienhardt C; Unité Mixte Internationale TransVIHMI (UMI 233 IRD - U1175 INSERM - Université de Montpellier), Montpellier, France.
  • Phillips PPJ; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA. Patrick.Phillips@ucsf.edu.
Trials ; 22(1): 515, 2021 Aug 03.
Article in En | MEDLINE | ID: mdl-34344435
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Estados Unidos